GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Foresee Pharmaceuticals Co Ltd (ROCO:6576) » Definitions » ROE % Adjusted to Book Value

Foresee Pharmaceuticals Co (ROCO:6576) ROE % Adjusted to Book Value : -9.03% (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Foresee Pharmaceuticals Co ROE % Adjusted to Book Value?

Foresee Pharmaceuticals Co's ROE % for the quarter that ended in Sep. 2024 was -144.70%. Foresee Pharmaceuticals Co's PB Ratio for the quarter that ended in Sep. 2024 was 16.03. Foresee Pharmaceuticals Co's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -9.03%.


Foresee Pharmaceuticals Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Foresee Pharmaceuticals Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Foresee Pharmaceuticals Co ROE % Adjusted to Book Value Chart

Foresee Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.70 -6.54 -3.38 -3.57 -9.16

Foresee Pharmaceuticals Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.12 -9.15 -3.47 -5.39 -9.03

Competitive Comparison of Foresee Pharmaceuticals Co's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Foresee Pharmaceuticals Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Foresee Pharmaceuticals Co's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Foresee Pharmaceuticals Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Foresee Pharmaceuticals Co's ROE % Adjusted to Book Value falls into.



Foresee Pharmaceuticals Co ROE % Adjusted to Book Value Calculation

Foresee Pharmaceuticals Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-96.17% / 10.50
=-9.16%

Foresee Pharmaceuticals Co's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-144.70% / 16.03
=-9.03%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Foresee Pharmaceuticals Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Foresee Pharmaceuticals Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Foresee Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 19-3, Sanchong Road, 9th Floor-2, Nangang District, Taipei, TWN, 115
Foresee Pharmaceuticals Co Ltd is engaged in the development and commercialization of new drugs using its proprietary drug delivery technology. Its main activity is to apply its Stabilized injectable formulation(SIF) platform technology to produce the products for anticancer and treatment of chronic disease. Its SIF product pipeline includes FP-001 for prostate cancer, FP-004 for Opioid drug addiction/Pain, FP-011 for Breast Cancer/Prostate Cancer, FP-016 for neurological diseases, and others. All of its revenue is generated from Taiwan.

Foresee Pharmaceuticals Co Headlines

No Headlines